Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 11 Recurrence 8 Lymphoma, Large B-Cell, Diffuse 6 Sezary Syndrome 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Mycosis Fungoides 3 Lymphoma, T-Cell, Cutaneous 3 Leukemia 3 Hodgkin Disease 3 Waldenstrom Macroglobulinemia 2 Neoplasms 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, T-Cell 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, Extranodal NK-T-Cell 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Immunoblastic Lymphadenopathy 2 Glioma 2 Glioblastoma 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Thyroid Neoplasms 1 Thyroid Diseases 1 Stomach Neoplasms 1 Somatostatinoma 1 Small Cell Lung Carcinoma 1

Interventions

Temozolomide 73 Bevacizumab 58 Radiotherapy 40 Radiosurgery 28 Carboplatin 23 Nivolumab 17 Etoposide 17 Cisplatin 17 pembrolizumab 16 Irinotecan 16 Ipilimumab 15 Magnetic Resonance Spectroscopy 14 Erlotinib Hydrochloride 14 Cyclophosphamide 14 Carmustine 14 Pemetrexed 13 Topotecan 10 Surgical Procedures, Operative 10 Capecitabine 10 Lapatinib 9 Filgrastim 9 Trastuzumab 8 Thalidomide 8 Sunitinib 8 Paclitaxel 8 Lomustine 8 Aminolevulinic Acid 8 encorafenib 7 binimetinib 7 Vincristine 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Brain Neoplasms × Panobinostat × Clear all

NCT04897880 2025-02-24

NORTH

Australian & New Zealand Children's Haematology/Oncology Group

Phase 2 Terminated

Brain Neoplasms, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡